-
Boston Scientific to Acquire SoniVie, Boosting Hypertension Treatment Portfolio
•
Boston Scientific Corporation (NYSE: BSX) is set to acquire SoniVie Ltd, an Israel-based medical device company known for its TIVUS intravascular ultrasound system. The TIVUS system is designed to treat hypertensive disorders, including renal artery denervation (RDN) for hypertension, by denervating nerves surrounding blood vessels. The product is expected to…
-
Boston Scientific Posts Strong Q4 and Full-Year 2024 Results
•
Boston Scientific Corporation (NYSE: BSX) released its Q4 and full-year 2024 financial report, showing robust growth across its business segments and geographies. Over the 12 months, the firm’s global net revenues reached USD 16.75 billion, up 17.6% year-on-year (YOY) in constant currency terms. During Q4’24, the US major recorded USD…
-
Boston Scientific’s FARAPULSE and WATCHMAN FLX Studies Show Positive Results
•
US major Boston Scientific Corporation (NYSE: BSX) has announced the presentation of positive results from the ADVANTAGE AF study for its FARAPULSE Pulsed Field Ablation (PFA) System and the OPTION study for its WATCHMAN FLX Left Atrial Appendage Closure (LAAC) Device at the AF Symposium 2025. These studies highlight the…
-
Boston Scientific Set to Acquire Bolt Medical for Up to USD 900 Million
•
US major Boston Scientific Corporation (NYSE: BSX) is set to acquire Bolt Medical, Inc., a company founded in 2019 with Boston Scientific’s backing, in which it currently holds a 26% stake. The transaction is structured to include an upfront payment of USD 43 million for the remaining 74% ownership that…
-
Boston Scientific Launches Athletis Peripheral Balloon Dilatation Catheter in China
•
US-based medical device leader Boston Scientific Corporation (NYSE: BSX) has announced the market launch of its Athletis peripheral balloon dilatation catheter in mainland China. This product is designed for percutaneous transluminal angioplasty (PTA) of the peripheral vascular system and is utilized in the treatment of stenotic lesions in autologous or…
-
Boston Scientific’s Next-Gen IVUS System AVVIGO+ Approved by China’s NMPA for Coronary Disease Use
•
US-based Boston Scientific Corporation (NYSE: BSX) has announced that China’s National Medical Products Administration (NMPA) has granted approval for its next-generation intravascular ultrasound (IVUS) diagnostic system, AVVIGO+, for use in diagnosing coronary heart disease. This marks a significant advancement in the diagnostic capabilities for cardiovascular healthcare in China. Multimodal Platform…
-
Boston Scientific Corporation to Acquire Intera Oncology Inc., Expanding Cancer Treatment Portfolio
•
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has announced a definitive acquisition agreement with fellow US firm Intera Oncology Inc., a company specializing in devices for the treatment of colorectal cancer and cholangiocarcinoma. The transaction is anticipated to be completed in the first half of 2025, marking a…
-
Boston Scientific Expands Neuromodulation Portfolio with Axonics Acquisition
•
Boston Scientific Corporation (NYSE: BSX), a leading player in the medical device industry, has announced the completion of its acquisition of Axonics, Inc. (NASDAQ: AXNX) for a substantial USD 3.7 billion. This strategic transaction is set to bolster Boston Scientific’s presence in the field of sacral neuromodulation (SNM), enhancing the…
-
Boston Scientific Launches Vercisie Genius DBS System in China for Parkinson’s Disease Treatment
•
US major Boston Scientific Corporation (NYSE: BSX) has officially launched its Vercisie Genius, an implantable deep brain stimulation (DBS) system, at the 7th CIIE. This move is set to enhance the treatment options available to China’s growing Parkinson’s disease (PD) population. Parkinson’s Disease and Deep Brain Stimulation TherapyParkinson’s disease (PD),…
-
Boston Scientific Corporation Announces Acquisition of Cortex, Inc.
•
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Cortex, Inc., a medical technology company under the Ajax Health umbrella. The financial details of the agreement have not been disclosed, and the transaction is expected to close in the first half of…
-
Boston Scientific Reports 19.5% YOY Increase in Q3 Net Sales, Driven by New Product Launches and Market Expansion
•
Boston Scientific Corporation (NYSE: BSX), a leading medical device manufacturer in the U.S., has announced its financial results for the third quarter of 2024, highlighting a robust 19.5% year-on-year (YOY) increase in net sales, which reached USD 4.209 billion. The company’s business units reported significant growth, with MedSurg contributing USD…
-
Advancing Peripheral Artery Disease Care: Boston Scientific’s JETSTREAM Receives Marketing Nod in China
•
NEW YORK—Boston Scientific Corporation (NYSE: BSX), a leading innovator in medical solutions, has secured a significant regulatory milestone with the National Medical Products Administration’s (NMPA) marketing approval for its JETSTREAM vascular plaque rotary cutting system. This development marks a significant step forward in the treatment of peripheral arterial disease (PAD)…
-
Boston Scientific Secures Silk Road Medical in a $1.16B Deal to Fortify Stroke Prevention Portfolio
•
Boston Scientific Corporation (NYSE: BSX), a leading innovator in medical devices, has announced a definitive agreement to acquire all outstanding shares of Silk Road Medical Inc. (NSDQ: SILK) for a purchase price of USD 27.5 per share in cash. This transaction, with an overall value of USD 1.16 billion, is…
-
Boston Scientific’s FARAPULSE Pulse Field Ablation System Earns NMPA Approval
•
Boston Scientific Corporation (NYSE: BSX), a leading medical device company in the U.S., has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its FARAPULSE pulse field ablation system. This system includes the FARAWAVE disposable cardiac pulse field ablation catheter and the FARASTAR cardiac…
-
Cryofocus Medtech Partners with Boston Scientific for Respiratory Products Distribution in China
•
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG: 6922), a Shanghai-based specialist in cryoablation treatment, has announced a strategic distribution agreement with the Shanghai subsidiary of US medical device giant Boston Scientific Corporation (NYSE: BSX). As per the terms of the agreement, Cryofocus is set to become the exclusive marketing partner and…
-
Boston Scientific Gets NMPA Approval for Agent DCB, First of Its Kind for Coronary ISR Treatment
•
Boston Scientific Corporation (NYSE: BSX), a leading medical device manufacturer in the U.S., has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its Agent paclitaxel coated PTCA balloon catheter (AGENT DCB). This product is designed for the treatment of coronary in-stent restenosis (ISR)…
-
Acotec Scientific and Boston Scientific Announce Comprehensive Collaboration Agreement
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a cooperation framework and service framework agreement with US firm Boston Scientific Group plc (BSG, NYSE: BSX), outlining a series of collaborations on global commercialization, product manufacturing service, product research and development (R&D), and other areas over the next three years.…
-
Acotec Scientific Holdings and Boston Scientific Group plc Sign MOU to Broaden Collaboration
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a memorandum of understanding (MoU) with US firm Boston Scientific Group plc (BSG, NYSE: BSX), signaling their intention to explore collaboration in multiple fields, including research and development (R&D), manufacturing, and marketing and sales. Financial details of the agreement were not…
-
Boston Scientific Partners with Scivita Medtech for Disposable Electronic Cholangioscope
•
Boston Scientific Corporation (NYSE: BSX), a leading figure in the medical device industry, has announced a partnership agreement with China-based Scivita Medical Technology Co., Ltd. The collaboration pertains to the development of a disposable electronic choledochoscope, although no financial details have been disclosed. Boston Scientific’s Extensive Business Presence in ChinaBoston…
-
Boston Scientific Launches Athletis Peripheral Balloon Dilatation Catheter in China
•
US-based medical device leader, Boston Scientific Corporation (NYSE: BSX), has announced the market launch of its Athletis peripheral balloon dilatation catheter in mainland China. The product is designed for percutaneous transluminal angioplasty (PTA) of the peripheral vascular system and is utilized in the treatment of stenotic lesions in autologous or…
